FDA warned Fresh Farms LLC about manufacturing violations in OTC hand sanitizer, including untested ethanol and missing batch records.
What happened
FDA inspected Fresh Farms LLC's drug manufacturing facility in Las Vegas, NV, from November 8 to November 11, 2021. FDA found the company lacked an adequate quality unit, did not test incoming components such as ethanol for methanol before use, did not perform release testing, and had no executed batch records for its OTC hand sanitizer. The company said it stopped drug production at the facility.
What FDA found
The company did not have an adequate quality unit, and its quality-control responsibilities were not written down or fully followed.
21 CFR 211.22(a) and 211.22(d)The company did not sample, test, or examine incoming components, including ethanol, before use, and did not test ethanol for methanol.
21 CFR 211.84(a)The company did not test each batch for identity and strength before release.
21 CFR 211.165(a)The company did not prepare executed batch production and control records.
21 CFR 211.188
What FDA wants
FDA tells Fresh Farms LLC to respond in writing within 15 working days with what it has done to correct the violations and prevent recurrence, and to give a completion schedule if it cannot finish in that time. FDA also says the firm must notify FDA before resuming drug manufacturing.
Who should pay attention
- brands that buy OTC hand sanitizer from contract manufacturers
- contract manufacturers of alcohol-based hand sanitizer
- companies that rely on product owners to source ethanol or other drug components
This is a summary. Read the original letter on fda.gov.